2 chapters across the catalog
Research published in the British Medical Journal warns that patients who stop taking GLP-1 drugs like Ozempic or Wegovy may face rapid weight gain and increased risks of diabetes and heart disease. Doctors emphasize that these medications are long-term commitments rather than quick fixes.
Antidepressant Weight Gain, Polypharmacy and Patient Anecdotes
Mainstream media outlets are reporting on the use of Ozempic to treat weight gain caused by antidepressants and antipsychotics. Critics argue this creates a cycle of polypharmacy where patients take additional drugs to manage the side effects of previous medications.
